425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. are pursuing a business combination, as detailed in a recent communication reposted by Strive's CRO.

Summary

• Strive, Inc. and Semler Scientific, Inc. are proposing a business combination.
• The communication regarding the proposed transaction was reposted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on October 2, 2025.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• The filing includes extensive cautionary statements regarding forward-looking statements and associated risks related to the merger.

Sentiment

Score: 6

Explanation: The filing announces a proposed business combination, a significant strategic event. However, it is primarily a cautionary statement regarding forward-looking information and risks associated with the transaction, maintaining a neutral and legally compliant tone rather than promotional.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits are expected to impact the combined company's future financial performance positively.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could affect anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including positive impacts on the combined company's future financial performance and successful integration of businesses. The timing of the closing of the proposed transaction is also a forward-looking expectation.

Industry Context

The mention of risks associated with Bitcoin treasury strategies suggests that at least one of the companies, or the combined entity, is engaging with or plans to engage with digital assets, aligning with a growing trend of corporate adoption of cryptocurrencies for treasury management.

Stakeholder Impact

• Shareholders: Potential dilution for Strive shareholders due to the issuance of additional Class A common stock. Semler Scientific stockholders will be asked to approve the transaction and will receive Strive shares. Changes in share price for both companies before closing are a risk.
• Customers: Potential adverse reactions from customers of both Strive and Semler Scientific.
• Employees: Potential changes to business or employee relationships at both companies.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• Strive will issue an Information Statement/Proxy Statement/Prospectus.
• The Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Merger, Acquisition, Business Combination, Strive Inc., Semler Scientific Inc., SEC Filing, Form 425, Corporate Governance, Risk Management, Bitcoin Treasury